Saturday, February 21, 2026
21.7 C
Bengaluru

Breaking Performance Barriers

[wpfilebase tag=file id=57 tpl=download-button /]

Inside this Issue

1. LinkedIn Leadership from K. Hariram

“How to lead a team of seniors” and “importance of keeping the ego in check when giving negative feedback” are issues covered in this edition.

2. Patient Access Part-III: Future of eHealthcare – Patient Convenience by Pankaj Mehrotra

Providing patients with an integrated health solution rather than just pills, is the future of pharma.

3. e-Pharmacies Are Here to Stay by Rinkesh Shah

Only a few compliance issues remain which can easily be ironed out. The consumer will benefit from this service.

4. Personalized Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

5. What Barcodes Can Bring to Patient Support Programmes by Amaninder S Dhillon

Barcoding medicine packs can throw up valuable data for pharma companies while enhancing patient compliance.

6. Real World Data: A Primer by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai

Unlike experimental data, real world data is more robust in terms of predicting outcomes, once inconsistancies are weeded out.

7. To, Every New Frontline Manager by K. Hariram

An open letter to every new Frontline Manager, in verse.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img